Apr 14, 2026 06:31AM Rodman & Renshaw Starts CAMP4 Therapeutics Corp (CAMP) at Buy

Apr 2, 2026 06:19AM CAMP4 Therapeutics Corp (CAMP) PT Raised to $9 at Leerink Partners

Mar 24, 2026 07:01AM CAMP4 appoints Michael MacLean to board of directors

Mar 6, 2026 07:07AM CAMP4 Therapeutics (CAMP) Reiterated at Overweight by Cantor Fitzgerald After Model Update

Dec 18, 2025 07:01AM CAMP4 partners with GSK on RNA therapeutics for $17.5 million upfront

Dec 11, 2025 07:04AM CAMP4 Therapeutics' (CAMP) Will Enjoy Cure SYNGAP1 Partnership - Cantor Fitzgerald

Oct 2, 2025 06:32AM Cantor Fitzgerald Starts CAMP4 Therapeutics Corp (CAMP) at Overweight

Oct 1, 2025 08:04AM CAMP4 begins toxicology studies for SYNGAP1 gene therapy candidate

Sep 16, 2025 02:11AM JPMorgan Downgrades CAMP4 Therapeutics Corp (CAMP) to Neutral

Sep 15, 2025 08:22AM CAMP4 Therapeutics Corp (CAMP) PT Lowered to $12 at Piper Sandler

Sep 10, 2025 02:14PM CAMP4 Therapeutics Corp (CAMP) PT Lowered to $7 at Leerink Partners

Aug 15, 2025 07:24AM Calamp Corp. (CAMP) Reports Q2 Loss of $0.62

Jun 30, 2025 08:00AM Sequans Appoints Jason W. Cohenour to Board of Directors

May 27, 2025 06:36AM Wedbush Starts CAMP4 Therapeutics Corp (CAMP) at Outperform

Jan 7, 2025 04:05PM CAMP4 Therapeutics (CAMP) Provides Corporate Updates and Highlights Key Upcoming Milestones

Nov 5, 2024 07:31AM William Blair Starts CAMP4 Therapeutics Corp (CAMP) at Outperform

Nov 5, 2024 06:21AM Leerink Partners Starts CAMP4 Therapeutics Corp (CAMP) at Outperform

Nov 5, 2024 03:46AM Piper Sandler Starts CAMP4 Therapeutics Corp (CAMP) at Overweight

Nov 5, 2024 03:00AM JPMorgan Starts CAMP4 Therapeutics Corp (CAMP) at Overweight

Oct 11, 2024 12:44PM Camp4 Therapeutics (CAMP) Opens At $11.16, IPO Priced At $11

Oct 11, 2024 06:01AM CAMP4 Therapeutics (CAMP) Prices 6.82M Share IPO at $11/sh

Oct 7, 2024 06:07AM CAMP4 Therapeutics (CAMP) Announces 5M Share IPO at $14-$16/sh

Sep 20, 2024 01:38PM CAMP4 Therapeutics (CAMP) Files for Proposed IPO